NCT04762407View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

February 24, 2021

Study Completion Date

February 24, 2021

Conditions
Healthy
Interventions
DRUG

HGP1910

Take it once per period.

DRUG

HGP1909

Take it once per period.

DRUG

HCP1903

Take it once per period.

Trial Locations (1)

Unknown

Korea University Anam Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY